Reason for request
Inclusion
Clinical Benefit
| Moderate |
Moderate AB pending re-assessment of oral antihistamines. |
Clinical Added Value
| no clinical added value |
No improvement in actual benefit (IAB V) compared with other oral H1 antihistamines available in oral form. |
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
R85ZVx01dXYnF9h6
